KCI Senior Leadership is composed of three scientific Associate Center Directors (ACDs) for Basic Sciences (Dr. Wei-Zen Wei), Clinical Sciences (Dr. Anthony Shields) and Population Sciences (Dr. Terrance Albrecht). A new senior leadership position, Scientific Director of Cores, has been added (Dr. Fred Miller) with responsibility for oversight and scientific leadership for the Cancer Center Cores. They are all supported by an ACD for Research Administration (Ms. Constance Claybaker) and overseen by the Deputy Center Director, Dr. Ann Schwartz. As President, CEO, and Center Director of the Karmanos Cancer Institute, Dr. Gerold Bepler bears ultimate responsibity for the administration and fiscal management of all KCI resources, including budgeting, personnel and faculty appointments, and space and equipment allocations. The primary responsibility of this team lies in ensuring that all of the Center's resources are optimally deployed to enhance the development of outstanding science as well as intra- and inter-programmatic interactions. These broad areas, each composed of more specific interests for investigation, define the role of the Senior Leaders to ensure the successful completion of broader scientific goals of the Institution through an active portfolio of individual Programs. The ACDs, by participating in such strategic committees as the ACD Committee, President's Committee, and Scientific Leadership Council, support ongoing discussions and debates about the allocation of resources. In addition, the scientific ACDs, oversee a discretionary fund of $750,000 annually to support pilot studies, the new post-doctoral program and recruitment opportunities during the year. Support is requested for Senior Leadership: Dr. Bepler (50% effort, 25% funding), Dr. A. Schwartz (25% effort, 10% funding), Dr. Wei (10% effort and funding), Dr. Shields (10% effort and funding), Dr. Albrecht (10% effort and funding), Ms. Claybaker (10% effort and funding) and Dr. F. Miller (25% effort and funding). Two of the scientific ACDs also serve as Program Leaders and funds for those efforts are requested elsewhere as is the funding for Ms. Claybaker as ACD of Research Administration.

Public Health Relevance

Members of Senior Leadership oversee the mission and strategic plans for the KCI scientific community. The team ensures all KCI resources are optimally deployed to enhance the development of outstanding science.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA022453-31S1
Application #
8709336
Study Section
Subcommittee G - Education (NCI)
Project Start
2013-09-30
Project End
2015-11-30
Budget Start
2013-09-30
Budget End
2013-11-30
Support Year
31
Fiscal Year
2013
Total Cost
$12,500
Indirect Cost
$4,276
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Bock, Cathryn H; Jay, Allison M; Dyson, Gregory et al. (2018) The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Res Treat 167:741-749
Hastert, T A; de Oliveira Otto, M C; LĂȘ-Scherban, F et al. (2018) Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the Multi-Ethnic Study of Atherosclerosis. Int J Obes (Lond) 42:433-440
Heyza, Joshua; Lei, Wen; Watza, Donovan et al. (2018) Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clin Cancer Res :
Mittal, Sandeep; Klinger, Neil V; Michelhaugh, Sharon K et al. (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414-421
Park, Hyo K; Schildkraut, Joellen M; Alberg, Anthony J et al. (2018) Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control 29:1081-1091
Su, Yongwei; Li, Xinyu; Ma, Jun et al. (2018) Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochem Pharmacol 148:13-26
Bonomi, Robin; Popov, Vadim; Laws, Maxwell T et al. (2018) Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [18F]-2-Fluorobenzoylaminohexanoicanilide. J Med Chem 61:7116-7130
Paximadis, Peter; Beebe-Dimmer, Jennifer L; George, Julie et al. (2018) Comparing Treatment Strategies for Stage I Small-cell lung Cancer. Clin Lung Cancer 19:e559-e565
Modi, Dipenkumar; Al-Kadhimi, Zaid; Chen, Wei et al. (2018) A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation. Am J Hematol 93:E96-E98
Patki, Mugdha; McFall, Thomas; Rosati, Rayna et al. (2018) Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Sci Rep 8:16006

Showing the most recent 10 out of 826 publications